A new study exploring the investigational therapy, Zorpo-cel, met its primary safety and secondary efficacy endpoints in ...
The U.S. Food and Drug Administration (FDA) issued a complete response letter requesting additional information from ...
Congress has taken the final steps in the FY 2026 budget process, passing legislation that increases funding for lupus programs, including $27 million - the most in history - for lupus programs at the ...
The U.S. Food and Drug Administration (FDA) has granted Biogen’s investigational drug, litifilimab, Breakthrough Therapy Designation for the treatment of cutaneous lupus erythematosus (CLE).
Black History Month serves as a reminder to actively amplify Black voices, share stories and raise awareness throughout the year. This month, we’re featuring Danielle Storr, a Black lupus warrior who ...
Our most recent episode of The Expert Series podcast explores the newly released SLE treatment guidelines and how they might affect patient care.
Interested in getting research like this straight to your inbox? Subscribe to our monthly Inside Lupus Research email for all the latest. Discover and match to lupus clinical trials faster with our ...
In this episode of the Lupus Foundation of America's The Expert Series podcast, we focus on the newly released American College of Rheumatology treatment guidelines for systemic lupus erythematosus ...
The U.S. Food and Drug Administration (FDA) approved Gazyva® to treat adults with lupus nephritis in October 2025. Gazyva targets and removes harmful B cells to help protect the kidneys in people with ...
To gain some insight into coping strategies specifically for men, we posed questions to six men about their lives with lupus. We think you will find their responses helpful and inspiring. Steven Helms ...
Learn more about how your company or organization can raise its profile and morale by becoming a corporate partner.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results